Thu.Jan 18, 2024

article thumbnail

Could long Covid’s signs of immune dysregulation in the blood lead to a diagnostic test?

STAT

Long Covid has long eluded scientists looking for its cause. Not knowing what triggers its persistent and distressing symptoms makes the condition challenging to treat; it’s hard to even say definitively who has it. New research published Thursday in Science has identified proteins present in the blood of people with long Covid that could point the way to a much-needed diagnostic test and possibly to future therapeutic targets.

article thumbnail

Navigating A Unique Journey: Dr. Lindsey Moseley’s Inspiring Path in Pharmacy Education

Pharmacy Is Right For Me

A pharmacy education provides diverse opportunities, ranging from patient care and research to education. Truly, no one path looks the same and there is no better example than Dr. Lindsey Moseley who found her passion for teaching and education whilst pursuing her Pharm.D. degree. Facing An Identity Crisis Dr. Lindsey Moseley is the Curricular Coordinator and a faculty member at Auburn University Harrison College of Pharmacy.

246
246
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Pumping breastmilk in bathrooms is a common, albeit unspoken, practice at health care conferences

STAT

Even though Erin Booth was not thrilled about having to travel to Philadelphia for a conference at six weeks postpartum, this one at least advertised having a private lactation space. This was back in 2013, when such accommodations were a rarity. The first bad sign was having to walk clear across the convention center to get there, cutting into her already brief pumping window.

363
363
article thumbnail

How to make 2024 a banner year for biopharma, despite the headwinds

PharmaVoice

Creative thinking is the name of the game as biopharmas seek to overcome a host of challenges — and investing with purpose, building trust and embracing tech could get them there.

130
130
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

STAT+: CRISPR-edited pig liver from eGenesis passes first test in brain-dead human, researchers say

STAT

For three days in December, an ICU room at the Hospital of the University of Pennsylvania bore witness to the first-ever merging of two powerful new technologies poised to change the future of transplant medicine. On a gurney, a brain-dead patient lay connected to a whirring Rube Goldberg-esque machine: a tangle of tubes and siphons on wheels. From a cannula on one end, blood from the patient entered, was pumped full of oxygen and other nutrients, then pushed into a cozy, temperature-controlled

Hospitals 363
article thumbnail

UK ATMP sector “robust”, research finds

European Pharmaceutical Review

An attractive destination for ATMP clinical trials Based on the Cell and Gene Therapy Catapult (CGT Catapult)’s recently published UK 2023 Advanced Therapy Medicinal Product (ATMP) Clinical Trials Database , the UK is an attractive location for ATMP clinical trials. This is largely due to the number of ongoing ATMP clinical trials in the UK remaining “largely stable” over the past three years.

111
111

More Trending

article thumbnail

Patients could be hesitant about Pharmacy First, warns Healthwatch England

The Pharmacist

Patient hesitancy and concerns about privacy could mean a slow uptake of Pharmacy First services, the head of policy, public affairs and research at Healthwatch England has warned. Speaking to the Health and Social Care Committee (HSCC)’s pharmacy inquiry this week, William Pett suggested that greater public awareness of pharmacy services was needed for patients […] The post Patients could be hesitant about Pharmacy First, warns Healthwatch England appeared first on The Pharmacist.

111
111
article thumbnail

STAT+: The FDA’s diagnostics chief, who led through Covid, has retired

STAT

Timothy Stenzel, the federal regulator who led the Food and Drug Administration’s diagnostics division during the chaotic time of Covid-19 pandemic, has left the agency. The FDA confirmed Thursday that Stenzel, who led the FDA’s office of in vitro diagnostics, retired at the end of 2023.  During the early days of the pandemic, Stenzel was in the middle of a turf battle between the Centers for Disease Control and Prevention and the FDA over the regulation of Covid tests.

363
363
article thumbnail

Bayer signals ‘significant’ layoffs in plan to shrink bureaucracy

BioPharma Dive

The company said it has secured agreement from labor representatives in Germany for job cuts that will shed “many managerial employees.

119
119
article thumbnail

Amid a dire nationwide therapist shortage, could lay counselors help close the gap?

STAT

One morning last May, 10 students and two instructors from across California gathered on Zoom to talk about empathy. Empathy, said instructor Elizabeth Morrison, is often undervalued. But it’s a crucial skill for any effective mental health care provider. People who find their way into this academy, she said, tend to already have a lot of empathy and be good at communicating it.

article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

The Impact of Eli Lilly's New DTC Platform on Rx Drug Sales and Patient Access: An Interview with Bill Roth, General Manager, Managing Partner, Blue Fin Group

Pharmaceutical Commerce

In an interview with Pharma Commerce editor Nicholas Saraceno, Bill Roth, General Manager, Managing Partner, Blue Fin Group, discusses changes that will come with the pharma giant's new platform.

105
105
article thumbnail

STAT+: Microsoft to embed AI tool for clinical documentation in Epic’s health records software

STAT

Microsoft on Thursday said it will launch its artificial intelligence tool for automating clinical documentation within health records software made by Epic, a move to embed the technology in health systems nationwide. The AI product, known as Dax Copilot, will automatically draft notes through Epic’s mobile application, known as Haiku, making it available for immediate review by clinicians.

article thumbnail

NICE backs Pfizer’s Talzenna for advanced breast cancer

pharmaphorum

Pfizer’s PARP inhibitor Talzenna has become the first targeted treatment for HER2-negative locally advanced or metastatic breast cancer with BRCA1/2 mutations to be recommended by NICE for routine NHS use.

109
109
article thumbnail

STAT+: Klobuchar urges drugmakers to remove patents FTC calls improper and inaccurate

STAT

Amid a push to crack down on patent abuse by the pharmaceutical industry, a key U.S. lawmaker is urging six large drug companies to remove dozens of patents that were identified by regulators as improperly or inaccurately listed with a federal registry. In a series of letters sent on Thursday, Sen. Amy Klobuchar (D-Minn.) demanded the companies explain why they have, so far, not responded to warnings issued two months ago by the Federal Trade Commission to remove more than 100 patents from the r

347
347
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Gene therapy biotech Jaguar spins out manufacturing company

BioPharma Dive

Called Advanced Medicine Partners, the new company will offer specialized cell and gene therapy manufacturing services to biotech and pharma clients.

111
111
article thumbnail

STAT+: How digital therapeutics companies are improvising when insurance coverage isn’t guaranteed

STAT

For years, the playbook for many companies that wanted to market digital therapeutics was stupid simple: Sell it like a prescription drug. But just because it was simple didn’t mean it was going to work. The bankruptcy of Pear Therapeutics last year proved that selling software-based treatments like drugs is harder than anticipated. Pear received Food and Drug Administration clearance for its app treating substance use disorders and insomnia but insurers mostly refused to cover the novel

335
335
article thumbnail

FDA clears AI skin cancer detection device from DermaSensor

pharmaphorum

Medtech company DermaSensor gets FDA approval for a handheld device, powered by AI, that can be used to detect skin cancer at the point of care

115
115
article thumbnail

STAT+: Apple Watch pulse oximeter feature removed to comply with ban

STAT

Apple will remove the blood oxygen measurement feature from its Apple Watches, the company announced Thursday. It’s the latest twist in a saga between Apple and medical device company Masimo. The International Trade Commission issued an import ban against Apple Watches in October after finding the blood oxygen feature too similar to Masimo’s.

311
311
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Market outlook to 2032: future trends across the seven major markets

European Pharmaceutical Review

The treatment markets for two key diseases areas: insomnia and the rare metabolic disorder, Gaucher disease, are predicted to flourish in the seven major markets (7MM – France, Germany, Italy, Spain, UK, US, and Israel) in 2032, data and analytics company GlobalData suggests. Insomnia market Dual orexin receptor antagonists (DORAs) [dual orexin receptor antagonists (DORAs)]… offer a new mechanism of action [in treating insomnia]” Across the seven major markets, the insomnia mar

article thumbnail

STAT+: Humana slashes profit predictions amid soaring Medicare Advantage costs

STAT

Humana’s Medicare Advantage enrollees got care in the hospital and physician clinics way more often than the company predicted at the end of 2023, forcing the health insurance giant on Thursday to drastically slash its profit projections for both 2023 and 2024. Those higher medical costs will wipe away more than $775 million of profit that Humana had expected to bank for 2023.

Hospitals 285
article thumbnail

Understanding the impact of AI on the advancement of gene therapy development

pharmaphorum

This page explores the significant impact of artificial intelligence (AI) on the advancement of gene therapy development within the biopharmaceutical field.

114
114
article thumbnail

Biotech layoffs, slumping stocks, and a 2024 preview

STAT

Why are rich biotechs cutting costs? Has JPM Week already worn off? And what’s going to move markets in 2024? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Jason Mast joins us to discuss an emerging trend in biotech: Cash-rich startups are laying off employees and tweaking their strategies amid a tough market for venture capital.

273
273
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Long-term findings from CAR NK cell therapy trial revealed

European Pharmaceutical Review

US researchers have reported promising outcomes from a Phase I/II trial in cancer patients treated with cord blood-derived CD19-targeted chimeric antigen receptor (CAR) natural killer (NK) cell therapy. Published in Nature Medicine , the findings revealed an overall response (OR) rate of 48.6 percent at 100 days post treatment. The one-year progression-free survival (PFS) and overall survival (OS) rates were reported to be 32 percent and 68 percent, respectively, in patients with relapsed or re

97
article thumbnail

Will Congress get any health policy done this year?

STAT

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine.  Sign up here  to receive it in your inbox on Tuesdays and Thursdays. Inside Congress’ health care policy breakdown Lawmakers are headed toward passage of a stopgap spending bill that funds the same health programs as the last one — but things were almost different, I scooped last night.

279
279
article thumbnail

Winners named in NHS healthcare inequality contest

pharmaphorum

AI-powered patient risk assessment company C2-Ai and the Sickle Cell Society have won an NHS contest to find solutions that can tackle health inequality

112
112
article thumbnail

Opinion: A new HHS rule rules takes a far too narrow approach to health care data interoperability

STAT

In 2016, the 21 st Century Cures Act required that the U.S. make progress toward interoperability, which it defined as “all electronically accessible health information” to be accessed, exchanged and used “without special effort on the part of the user.” In December, seven years after the passage of the bill, the Department of Health and Human Services finalized a rule that will penalize providers for blocking access to electronic health information.

264
264
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Glenmark Life Sciences signs MSA with Japanese pharma company

Express Pharma

Glenmark Life Sciences has signed a Master Supply Agreement (MSA) with a Japanese innovator pharma company. Under the aegis of the Master Supply Agreement, Glenmark Life Sciences will manufacture API in the therapeutic area of urinary anti-spasmodic, to supply to the Japanese firm. As part of this collaboration, product portfolios of various affiliates of the Japanese company may also be added in the future.

109
109
article thumbnail

The XBI comedown after JPM

STAT

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning, all. Damian here with a look at biotech’s early-year volatility, the debut of a new venture fund, and the perils of accepting reality.

article thumbnail

NHSE: Sign up to Pharmacy First IT by tomorrow in time for launch

The Pharmacist

Community pharmacies in England must sign up with an IT supplier for Pharmacy First by Friday 19 January in order to be listed as providing the service when it launches in two weeks’ time. They must also sign up to provide Pharmacy First on the Manage Your Service (MYS) portal – which supports with reimbursement […] The post NHSE: Sign up to Pharmacy First IT by tomorrow in time for launch appeared first on The Pharmacist.

article thumbnail

STAT+: Pipelines from high school to health care jobs to be created by new Bloomberg Philanthropies initiative

STAT

The Edward M. Kennedy Academy for Health Careers will be revamped to create a guaranteed path to jobs at Mass General Brigham thanks to a multimillion investment from Bloomberg Philanthropies, the foundation announced Wednesday. The school, an in-district charter within Boston Public Schools, is one of 10 schools and districts around the country that will be funded by a new $250 million initiative.

Hospitals 243
article thumbnail

Inceptua and Cycle partnership brings hope to patients at the end of the treatment road

Outsourcing Pharma

Inceptua Group and Cycle Pharmaceuticals partnership will give access to Free Goods Partnership that gets medicine to patients with extremely rare genetic conditions, which they would be unable to access otherwise.

101
101